Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 17, 2007

Nano-Terra and 3M Enter Nanotech Partnership

  • Nano-Terra inked a multiyear development and licensing agreement with 3M . The agreement is designed to bring to market innovative, nanotechnology-based products and solutions made possible by nanoscale, molecular fabrication methods pioneered by Nano-Terra co-founder George Whitesides, Ph.D., at Harvard University and the company’s scientists.

    The Cambridge-based firm is employing the design and manipulation of molecular structures for the creation of new properties and functionalities in materials.

    "3M is an innovative, diversified technology company with a stable of well-known brands and is a global leader in commercializing nanotechnology,” notes Carmichael Roberts, vice chairman and co-founder of Nano-Terra. “As a first step, we are focusing on how our expertise in soft lithography and in molecular self-assembly can support 3M's own development work in certain application areas."

    The co-development work will be performed primarily at Nano-Terra's lab facilities in Cambridge, with frequent input from and milestone reviews by 3M.


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »